Clinical Trial Update: Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing NN1250 with sitagliptin in adults with Type 2 diabetes who have never used insulin has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NN1250
• Sitagliptin (sitagliptin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2015-11-18